Old Web
English
Sign In
Acemap
>
Paper
>
EXPLORING THE UTILITY OF CSF NEUROGRANIN LEVELS IN AN ALZHEIMER’S DISEASE CLINICAL TRIAL
EXPLORING THE UTILITY OF CSF NEUROGRANIN LEVELS IN AN ALZHEIMER’S DISEASE CLINICAL TRIAL
2016
Jeffrey L. Dage
Peter Castelluccio
Wesley Anderson
Peng Yu
Jayne A. Talbot
Bradley B. Miller
Elizabeth M. Herries
Dan L. Crimmins
Jack H. Ladenson
Anne M. Fagan
David M. Holtzman
David Henley
Eric Siemers
Robert A. Dean
Keywords:
Clinical trial
Psychology
Psychiatry
Disease
Neurogranin
Physical therapy
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]